ALRISE Biosystems GmbH is a drug-delivery company focused on advanced nano- and micro-encapsulation for drug development. ALRISE's core business includes controlled-release formulations (parenteral delivery) and targeting of gastrointestinal tract (oral delivery). ALRISE's mission is to make its highly innovative and world-wide patented encapsulation technology available to a broader user spectrum as well as to create benefits for patients worldwide.